- Weighing up pros and cons of different outsourcing models: which is best for your trial?
- When is mixing and matching better than fully outsourcing or keeping trials fully in house?
- Developing an outsourcing strategy as a small to medium sized biotech with limited resources
- Why is FSP becoming a popular choice among sponsor companies and how can this support meeting trial timelines?
- How early engagement can improve outcomes
- Unlocking the value of your pipeline
- Purposeful partnering with bespoke solutions
- Results of a collaborative industry survey on the use of AI and machine learning within clinical research and development
- Mapping AI usage and level of adoption
- Examine perceptions and attitudes regarding use of AI and machine learning and challenges to implementation
- Understanding the role of Key Opinion Leaders beyond data collection
- Educating CRAs on the impact of safeguarding future customer relationships
- Prioritizing site satisfaction for patient happiness
- Enhancing patient outcomes through site relationship building
- Importance of retention and growth for your team
- Openness to junior clinical team members
- Openness to bridge programs with vendor partner
- Navigating these challenges in a hybrid environment
- Overview of the value proposition and expected financial return of patient engagement practices
- Review of current adoption levels of patient engagement practices
- Assessment of the impact of patient engagement practices on performance and quality
- Discussion of opportunities to optimize patient engagement and its impact
- Priorities and strategies for small biotech in partnering with CROs and vendors
- Breaking down the myths
- Identifying the right partners
- Cultivating collaborative relationships
- Managing the partnership
- Navigating the constantly evolving vendor and CRO landscape as a small to mid sized sponsor company
- Staff turnover and layoffs: handling changes in the industry in order to ensure success
- New regulations and guidance around clinical trials in the US: how will this impact you?
- An overview of technology and innovation in the clinical trial industry: what’s working and what isn’t?
